Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.3B
Avg Funding
$50.3M
Global Reach
6
countries

Top Cities for Therapeutics

Cambridge
Jupiter
Hawthorn
London
San Francisco
Admiralty

Recently Funded Companies

Export
Cambridge, United States

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Mar 2026

Founder Contacts

41,000+ verified contacts

Jupiter, United States

Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.

$2.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Hawthorn, Australia

Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.

$1.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Amber Therapeutics develops the next-generation of bioelectrical therapies.

Mar 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Mave Health provides digital mental healthcare services focused on therapy, psychiatric support, and structured care programs.

$2.1M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Admiralty, Hong Kong

Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.

$27.7M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

La Jolla, United States

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

$75.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

$77.5M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

$40.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Sioux Falls, United States

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

$85.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Santa Cruz, United States

Unnatural Products is a biotech company that focuses on unlocking macrocyclic peptides to create drug therapies.

$45.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

$550.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

$7.6M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Umeå, Sweden

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

$9.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Miami, United States

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

$30.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Belfast, United Kingdom

SignaCor is a clinical-stage biotech company exploring therapeutics for cardiac disorders, specifically hypertrophic cardiomyopathy.

$332K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

$85.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

$10.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

Defence Therapeutics is a scientific pioneer on a journey to uncover enhanced treatment solutions for future generations.

$7.1M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Swarm Oncology is a biotechnology company that develops novel T cell therapies for cancer patients.

$8.1M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.

$19.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

$40.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.

$105.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

$9.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Westport, United States

Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.

$22.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Showing 301 to 325 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$50.3M
Total Funding Tracked
$1.3B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Cambridge
7 companies$827.6M
2.London
3 companies$85.6M
3.Jupiter
1 companies$2.0M
4.Hawthorn
1 companies$1.0M
5.San Francisco
1 companies$2.1M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked